The kit is designed for quantitative detection of the hepatitis B virus DNA in patients with suspected infection and determination of viral load in patients with the detected hepatitis B virus to choose an appropriate therapy and evaluate its effectiveness.
The kit is designed for quantitative detection of the hepatitis C virus RNA in patients with suspected infection and patients with the detected hepatitis C virus in order to choose an appropriate therapy and evaluate its effectiveness.
The kit is designed for qualitative and quantitative detection of hepatitis D virus RNA in patients with suspected infection and determination of viral load in patients with detected hepatitis D virus to choose the correct therapy and evaluate its effectiveness.
The kit is designed for detection of the hepatitis C virus and its genotypes (1a,1b, 2, 3, 4, 5a, 6) in patients with the detected virus to choose an appropriate antiviral therapy, to predict and evaluate the course of the disease and possible complications.
The kit is designed for detection and differentiation of human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) in order to diagnose the HIV infection and choose an antiretroviral therapy regimen.
The kit is designed for quantitative detection of the human immunodeficiency virus (HIV-1) in order to diagnose the HIV infection, choose an antiretroviral therapy regimen, monitor the progression of the HIV infection and/or the effectiveness of the antiretroviral therapy, and is also recommended for dispensary registration.